会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 31. 发明授权
    • Process and intermediates for preparing compounds having a disubstituted
acetylene moiety and retinoic acid-like biological activity
    • 用于制备具有二取代乙炔部分和视黄酸样生物活性的化合物的方法和中间体
    • US5248777A
    • 1993-09-28
    • US731161
    • 1991-07-15
    • Roshantha A. S. Chandraratna
    • Roshantha A. S. Chandraratna
    • C07D215/06C07D215/14C07D311/58C07D335/06C07D401/06C07D405/06C07D409/06
    • C07D335/06C07D215/06C07D215/14C07D311/58C07D401/06C07D405/06C07D409/06
    • A process is disclosed for the preparation of disubstituted acetylene derivatives having retinoic acid like biological activity, wherein 6-ethynyl-chroman, 6-ethynyl-thio chroman and 6-ethynyl-1,2,3,4-tetrahydroquinoline derivatives of the formula shown below are reacted in the presence of catalysts with halogenated phenyl or heteroaryl derivatives of the formula shown below to provide the disubstituted acetylenes.In the formulae the symbols have the following meanings. R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 are hydrogen or lower alkyl groups (of 1-6 carbons) where R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 may be identical or different from one another) X is S, O or NR' where R' is hydrogen or lower alkyl, Z represents hydrogen, or a metal ion capable of forming a salt with the ethynyl moiety of the molecule, X' is a leaving group such as a halogen group, A is phenyl, or heteroaryl such as pyridinyl, thienyl, furyl, pyridazinyl, pyrimidinyl, pyrazinyl, thiazolyl or oxazolyl, n is an integer between 0 to 5, and B is H, --COOH or a pharmaceutically acceptable salt, ester or amide thereof, --CH.sub.2 OH or an ether or ester derivative, or --CHO or an acetal derivative, or --COR.sub.1 or a ketal derivative where R.sub.1 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons. ##STR1##
    • 公开了制备具有视黄酸类生物学活性的二取代乙炔衍生物的方法,其中所示的式为6-乙炔基 - 苯并二氢吡喃,6-乙炔基 - 硫代色满和6-乙炔基-1,2,3,4-四氢喹啉衍生物 在催化剂存在下使下文所示的下式所示的卤代苯基或杂芳基衍生物反应,得到二取代的乙炔。 在公式中,符号具有以下含义。 R 1,R 2,R 3,R 4和R 5是氢或低级烷基(1-6个碳),其中R 1,R 2,R 3,R 4和R 5可以相同或不同)X是S,O或NR' R'是氢或低级烷基,Z表示氢,或能够与分子的乙炔基部分形成盐的金属离子,X'是离去基团如卤素基团,A是苯基或杂芳基如吡啶基 ,噻吩基,呋喃基,哒嗪基,嘧啶基,吡嗪基,噻唑基或恶唑基,n是0-5之间的整数,B是H,-COOH或其药学上可接受的盐,酯或酰胺,-CH 2 OH或醚或酯衍生物 或-CHO或缩醛衍生物,或-COR1或缩酮衍生物,其中R1是含有1至5个碳原子的烷基,环烷基或烯基。
    • 36. 发明授权
    • Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
    • 使用具有类视黄醇样活性和降低皮肤毒性并缺乏致畸作用的化合物治疗方法
    • US06624188B1
    • 2003-09-23
    • US08216990
    • 1994-03-23
    • Roshantha A. S. Chandraratna
    • Roshantha A. S. Chandraratna
    • A61K31382
    • C07D213/80C07D307/68C07D311/74C07D333/38
    • A process and pharmaceutical compositions for treating several diseases and conditions which are normally treatable with retinoid like compounds are disclosed where the compound used for the treatment are substantially non-teratogenic and not irritant to the skin. The process is useful for treating female mammals, including humans, who are pregnant or in the child bearing age. An important partial structural feature of the compounds which provides the non-teratogenic effect and lack of irritation of skin is shown by the formula where the partially drawn ring signifies an aromatic ring which may be carbocyclic or heteroaromatic, 6-membered or 5-membered, and may be condensed with another ring. R1 is lower alkyl, Cl, Br, or I, R2 is H, lower alkyl, Cl, Br, or I, and R3 is lower alkyl, Cl, Br, I, or is an ether, thioether, ester, thioester, amine or substituted amine group.
    • 公开了用于治疗通常用类视黄醇类化合物治疗的几种疾病和病症的方法和药物组合物,其中用于治疗的化合物基本上是非致畸性的并且不刺激皮肤。 该过程可用于治疗怀孕或生育年龄的女性哺乳动物,包括人类。 提供非致畸作用和缺乏皮肤刺激性的化合物的重要部分结构特征由下式示出:其中部分拉伸的环表示可以是碳环或杂芳族的芳族环,6元或5元, 并且可以与另一个环稠合。 R1是低级烷基,C1,Br或I,R2是H,低级烷基,C1,Br或I,R3是低级烷基,C1,Br,I,或是醚,硫醚,酯,硫酯,胺 或取代的胺基。
    • 40. 发明授权
    • Acetylenes disubstituted with a heteroaromatic group and a substituted
phenyl group having retinoid like activity
    • 用杂芳基取代的乙炔和具有类视黄醇样活性的取代苯基
    • US5516904A
    • 1996-05-14
    • US384886
    • 1995-02-07
    • Roshantha A. S. Chandraratna
    • Roshantha A. S. Chandraratna
    • C07D213/80A61K31/425
    • C07D213/80
    • Retinoid like activity is exhibited by compounds of the formula ##STR1## where R.sub.1 -R.sub.3 independently are hydrogen, lower alkyl, cycloalkyl or lower alkenyl, A and B independently are hydrogen, lower alkyl, cycloalkyl, lower alkenyl, SR.sub.4 or OR.sub.4 where R.sub.4 is lower alkyl, cycloalkyl or lower alkenyl; Y is selected from a group consisting of pyridazinyl, pyrimidinyl, pyrazinyl or oxazolyl; E is lower alkenyl, lower alkynyl, lower cycloalkyl, lower branched chain alkyl, or is characterized by the formula (CH.sub.2).sub.n where n is 0-5, and Z is H, OH, OR.sub.5, OCOR.sub.5, --COOH or a pharmaceutically acceptable salt, ester or amide thereof, --CH.sub.2 OH, CH.sub.2 OR.sub.6, CH.sub.2 OCOR.sub.6, or --CHO, CH(OR.sub.7).sub.2, CHOR.sub.8 O, or COR.sub.9, CR.sub.9 (OR.sub.7).sub.2, CR.sub.9 OR.sub.8 O where R.sub.5 is lower alkyl, phenyl or lower alkylphenyl, R.sub.6 is lower alkyl, phenyl or lower alkylphenyl, R.sub.7 is lower alkyl, R.sub.8 is a divalent alkyl radical of 2-5 carbons, and R.sub.9 is an alkyl, cycloalkyl or alkenyl group containing 1 to 5 carbons.
    • 其中R 1 -R 3独立地是氢,低级烷基,环烷基或低级链烯基,A和B独立地是氢,低级烷基,环烷基,低级烯基,SR4或OR4,其中R4是 低级烷基,环烷基或低级烯基; Y选自哒嗪基,嘧啶基,吡嗪基或恶唑基; E为低级链烯基,低级炔基,低级环烷基,低级支链烷基,或其特征为式(CH2)n,其中n为0-5,Z为H,OH,OR5,OCOR5,-COOH或药学上可接受的 其盐,酯或酰胺,-CH 2 OH,CH 2 OR 6,CH 2 OCOR 6或-CHO,CH(OR 7)2,CHOR 8 O或COR 9,CR 9(OR 7)2,CR 9OR 8 O,其中R 5为低级烷基,苯基或低级烷基苯基, 烷基,苯基或低级烷基苯基,R7为低级烷基,R8为2-5个碳原子的二价烷基,R9为含有1至5个碳原子的烷基,环烷基或链烯基。